Cargando…
Betulinic Acid Selectively Increases Protein Degradation and Enhances Prostate Cancer-Specific Apoptosis: Possible Role for Inhibition of Deubiquitinase Activity
Inhibition of the ubiquitin-proteasome system (UPS) of protein degradation is a valid anti-cancer strategy and has led to the approval of bortezomib for the treatment of multiple myeloma. However, the alternative approach of enhancing the degradation of oncoproteins that are frequently overexpressed...
Autores principales: | Reiner, Teresita, Parrondo, Ricardo, de las Pozas, Alicia, Palenzuela, Deanna, Perez-Stable, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570422/ https://www.ncbi.nlm.nih.gov/pubmed/23424652 http://dx.doi.org/10.1371/journal.pone.0056234 |
Ejemplares similares
-
Mcl-1 protects prostate cancer cells from cell death mediated by chemotherapy-induced DNA damage
por: Reiner, Teresita, et al.
Publicado: (2015) -
ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells
por: Parrondo, Ricardo, et al.
Publicado: (2013) -
Inhibiting Multiple Deubiquitinases to Reduce Androgen Receptor Expression in Prostate Cancer Cells
por: de las Pozas, Alicia, et al.
Publicado: (2018) -
NF-κB activation enhances cell death by antimitotic drugs in human prostate cancer cells
por: Parrondo, Ricardo, et al.
Publicado: (2010) -
Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis
por: Wang, Siyu, et al.
Publicado: (2017)